Figure 6From: Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring Outline of the framework for registry-based MS monitoring on different EEA populations, assuming stable annual MSI (N onsets per year) and MS diagnostic improvement secondary to synergistic effects of improved access to neurological expertise (NE), CSF oligoclonal bands, neurophysiological tests and visual evoked potentials (CSF-EP), and magnetic resonance imaging (MRI). Back to article page